Abstract:Harmonizing serology measurements is critical for identifying reference materials that permit standardization and comparison of results across different diagnostic platforms. However, the theoretical foundations of such tasks have yet to be fully explored in the context of antibody thermodynamics and uncertainty quantification (UQ). This has restricted the usefulness of standards currently deployed and limited the scope of materials considered as viable reference material. To address these problems, we develop rigorous theories of antibody normalization and harmonization, as well as formulate a probabilistic framework for defining correlates of protection. We begin by proposing a mathematical definition of harmonization equipped with structure needed to quantify uncertainty associated with the choice of standard, assay, etc. We then show how a thermodynamic description of serology measurements (i) relates this structure to the Gibbs free-energy of antibody binding, and thereby (ii) induces a regression analysis that directly harmonizes measurements. We supplement this with a novel, optimization-based normalization (not harmonization!) method that checks for consistency between reference and sample dilution curves. Last, we relate these analyses to uncertainty propagation techniques to estimate correlates of protection. A key result of these analyses is that under physically reasonable conditions, the choice of reference material does not increase uncertainty associated with harmonization or correlates of protection. We provide examples and validate main ideas in the context of an interlab study that lays the foundation for using monoclonal antibodies as a reference for SARS-CoV-2 serology measurements.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the uncertainty and standardization in antibody measurement. Specifically, the paper aims to solve the following key issues through theoretical and experimental methods: 1. **Standardize and compare results of different diagnostic platforms**: The paper emphasizes the importance of achieving result standardization in serological measurement so as to be able to identify appropriate reference materials and thus standardize and compare results on different diagnostic platforms. However, currently, based on the theoretical basis of antibody thermodynamics and uncertainty quantification (UQ), these tasks have not been fully explored. 2. **Select the best reference materials**: The paper explores how to select the "best" reference materials in clinical or research settings. This issue involves how to compare different reference materials and determine which materials can be used as effective reference standards. 3. **Define correlates of protection**: The paper also attempts to define correlates of protection, which is still an elusive concept to this day. Correlates of protection refer to indicators that can predict an individual's level of immune protection against infection by a specific pathogen, such as SARS - CoV - 2. 4. **Reduce measurement uncertainty**: The paper proposes a hierarchical data analysis and statistical method based on thermodynamics and conditional probability to identify and quantify the sources of uncertainty that affect the use of reference materials. Through these methods, the paper hopes to reduce the measurement uncertainty caused by factors such as reference material selection, detection methods, instruments, and operator effects. 5. **Verify the effectiveness of monoclonal antibodies as reference materials**: The paper verifies the feasibility of using monoclonal antibodies as reference materials for SARS - CoV - 2 serological measurement through an inter - laboratory study. This lays the foundation for using monoclonal antibodies as reference standards in the future. ### Main contributions - **Theoretical framework**: The paper proposes a strict theoretical framework for antibody normalization and standardization, as well as a probability model for defining correlates of protection. - **Thermodynamic description**: Through the thermodynamic description of antibody binding, the paper establishes the relationship between serological measurement and Gibbs free energy, thereby deriving a regression analysis method for direct standardization measurement. - **Optimized normalization method**: The paper proposes an optimization - based normalization method to check the consistency between reference materials and sample dilution curves. - **Uncertainty propagation technique**: The paper uses the uncertainty propagation technique to estimate correlates of protection and proves that under physically reasonable conditions, the selection of reference materials will not increase the uncertainty of standardization or correlates of protection. - **Experimental verification**: The paper verifies the main points through an inter - laboratory study, especially in terms of using monoclonal antibodies as reference materials for SARS - CoV - 2 serological measurement. ### Key conclusions - **The difference between standardization and normalization**: The paper clarifies that standardization and normalization are two different tasks and provides an accurate mathematical definition to distinguish them. - **The influence of reference materials**: The paper points out that under physically reasonable conditions, the selection of reference materials will not increase the uncertainty of standardization or correlates of protection. - **The feasibility of monoclonal antibodies**: The paper verifies through experiments that monoclonal antibodies can be used as effective reference materials, and their performance is comparable to that of human - derived reference materials. In conclusion, through theoretical and experimental methods, this paper systematically solves the standardization and uncertainty problems in antibody measurement, providing an important theoretical basis and technical support for future serological research.

Uncertainty Quantification of Antibody Measurements: Physical Principles and Implications for Standardization

Experimental Validation and Broader Implications for Correlates of Protection

Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19

Development and Validation of Measurement Traceability for In Situ Immunoassays

Standardization of flow cytometric detection of the antigen expression

Optimized Normalization for Antibody Microarrays and Application to Serum-Protein Profiling

qNMR characterization of potential peptide calibrators for isotope dilution LC–MS quantification of a SARS-CoV-2 IgG monoclonal antibody

Multivalent binding model quantifies antibody species from systems serology

Study of SARS-CoV-2 Spike Protein Wild-Type and the Variants of Concern Real-Time Interactions with Monoclonal Antibodies and Convalescent Human Serum

Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis

Removing Negative Impacts from Inevitable Nonreproducible and Nonspecific Antibody-Probe Interactions in Viral Serology

B-043 Q-nabTM Igg kit: verification and validation of a novel cell-free quantitative neutralizing antibody assay

MALDI-TOF-MS-Based Identification of Monoclonal Murine Anti-SARS-CoV-2 Antibodies within One Hour

Antibody characterization is critical to enhance reproducibility in biomedical research

Development of a unit conversion tool for five quantitative anti-spike assays and agreement analysis of three qualitative anti-nucleocapsid assays for SARS-CoV-2

Absolute quantitation of binding antibodies from clinical samples

A novel framework to quantify uncertainty in peptide-tandem mass spectrum matches with application to nanobody peptide identification

Using Bland-Altman plot-based harmonization algorithm to optimize the harmonization for immunoassays

Analytical measuring interval, linearity, and precision of serology assays for detection of SARS-CoV-2 antibodies according to CLSI guidelines

One-Step Quantification of anti-Covid-19 Antibodies via Dual Affinity Ratiometric Quenching Assays

Comparative analysis of eleven SARS-CoV-2 immunoassays and neutralisation data: time to enhance standardisation and correlation of protection